Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
5,163,108
-
Share change
-
-4,150,726
-
Total reported value
-
$903,416
-
Price per share
-
$0.18
-
Number of holders
-
22
-
Value change
-
-$741,070
-
Number of buys
-
7
-
Number of sells
-
9
Institutional Holders of TRACON PHARMACEUTICALS INC - COM NEW (TCON) as of Q4 2023
As of 31 Dec 2023,
TRACON PHARMACEUTICALS INC - COM NEW (TCON) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,163,108 shares.
The largest 10 holders included
Ikarian Capital, LLC, ACADIAN ASSET MANAGEMENT LLC, Squarepoint Ops LLC, VANGUARD GROUP INC, BlackRock Inc., BOOTHBAY FUND MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, and JOHNSON & JOHNSON.
This page lists
22
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.